Smith & Nephew plc (NYSE:SNN) Given Consensus Rating of “Hold” by Analysts

Smith & Nephew plc (NYSE:SNN) has received an average recommendation of “Hold” from the five analysts that are currently covering the company, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating on the company.

Separately, StockNews.com upgraded Smith & Nephew from a “buy” rating to a “strong-buy” rating in a report on Friday, March 15th.

Smith & Nephew Trading Down 2.8 %

Shares of SNN opened at $23.88 on Tuesday. Smith & Nephew has a 12 month low of $21.52 and a 12 month high of $33.08. The stock has a fifty day moving average price of $26.06 and a 200-day moving average price of $25.96. The company has a current ratio of 1.77, a quick ratio of 0.72 and a debt-to-equity ratio of 0.44.

Smith & Nephew Announces Dividend

The company also recently announced a semi-annual dividend, which will be paid on Wednesday, May 22nd. Investors of record on Tuesday, April 2nd will be paid a $0.462 dividend. The ex-dividend date of this dividend is Monday, April 1st. This represents a yield of 2.8%.

Hedge Funds Weigh In On Smith & Nephew

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SNN. CWM LLC raised its stake in Smith & Nephew by 68.6% in the 4th quarter. CWM LLC now owns 954 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 388 shares during the last quarter. Allworth Financial LP raised its stake in Smith & Nephew by 1,566.2% in the 3rd quarter. Allworth Financial LP now owns 1,133 shares of the medical equipment provider’s stock worth $28,000 after acquiring an additional 1,065 shares during the last quarter. Spire Wealth Management raised its stake in Smith & Nephew by 224.3% in the 4th quarter. Spire Wealth Management now owns 1,015 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 702 shares during the last quarter. EverSource Wealth Advisors LLC raised its stake in Smith & Nephew by 75.0% in the 4th quarter. EverSource Wealth Advisors LLC now owns 1,227 shares of the medical equipment provider’s stock worth $33,000 after acquiring an additional 526 shares during the last quarter. Finally, Parallel Advisors LLC raised its stake in Smith & Nephew by 150.9% in the 4th quarter. Parallel Advisors LLC now owns 1,533 shares of the medical equipment provider’s stock worth $42,000 after acquiring an additional 922 shares during the last quarter. Hedge funds and other institutional investors own 25.64% of the company’s stock.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.